ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden

Wang Y.-H.CHIEN-CHIN LINLee S.-H.CHENG-HONG TSAIWu S.-J.HSIN-AN HOUTAI-CHUNG HUANGKuo Y.-Y.MING YAOKOPING CHANGCHUNG-WU LINYUN-CHU LINFENG-MING TIENWEN-CHIEN CHOUJIH-LUH TANGHWEI-FANG TIEN2020-10-202020-10-2020202044-5385https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092361649&doi=10.1038%2fs41408-020-00364-5&partnerID=40&md5=a2b0f5d04ad81bb35280b87eb83d2e43https://scholars.lib.ntu.edu.tw/handle/123456789/517205en[SDGs]SDG3ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burdenletter10.1038/s41408-020-00364-52-s2.0-85092361649